Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions
ABSTRACT Dementia of motor neuron disease type (DMND) is a variety of frontotemporal dementia (FTD) which is pathologically defined by characteristic neuronal ubiquitinated, tau- and synuclein-negative intracytoplasmic inclusions. Many cases with this pathology, however, do not have motor neuron disease. In the present study, we document the presence of ubiquitinated neuronal intranuclear inclusions in a sub-population of cases of neuropathologically verified DMND. Immunohistochemical localization of ubiquitin was performed on sections of post-mortem brain from 12 patients with DMND as well as from cases with other neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's disease, dementia with Lewy bodies, corticobasal degeneration, progressive supranuclear palsy, and multiple system atrophy. All of the cases of DMND showed ubiquitinated, tau-negative intracytoplasmic inclusions in dentate granule cells and cortical neurons. Of these 12 cases of DMND, 3 also showed neuronal ubiquitinated intranuclear inclusions. In 1 of these cases, CAG repeat expansions in the genes known to harbor these mutations were excluded. Cases with intranuclear inclusions displayed striatal atrophy and reduced brain weight relative to non-inclusion-bearing cases. In addition, patients with intranuclear inclusions tended to have a younger age of onset, a prolonged duration of disease, absence of motor neuron symptoms, and a family history of dementia. Intranuclear inclusions were not identified in the control cases with other neurodegenerative diseases. Ubiquitinated neuronal intranuclear inclusions have not been reported previously in DMND. The presence of ubiquitinated intranuclear inclusions along with striatal atrophy in a subset of cases of DMND may signify the existence of a neuropathologically distinct subset of this unique form of FTD.
- SourceAvailable from: Cord Naujokat
- "Ubiquitin ELISA, cerebrospinal fluid, serum [42 – 45] Parkinson's disease Ubiquitin (+) Immunocytochemistry, brain specimen [57 – 59,62] Parkin (+) Immunocytochemistry, brain specimen  Parkin (+) PCR, peripheral blood leukocytes    Dementia with Lewy bodies Ubiquitin (+) Immunocytochemistry, brain specimen     Pick's disease Ubiquitin (+) Immunocytochemistry, brain specimen     Amyotrophic lateral sclerosis Ubiquitin (+) Immunocytochemistry, brain specimen   Huntington's disease Ubiquitin (+) Immunocytochemistry, brain specimen   Creutzfeld – Jakob disease Ubiquitin (z) RIA, cerebrospinal fluid  Cancer Renal cancer Proteasome subunits C2 and C9 (z) PCR, immunocytochemistry, tumor biopsy   20S Proteasome (z) ELISA, serum    Gastric cancer 20S Proteasome (z) ELISA, serum    Myeloid leukemia 20S Proteasome (z) ELISA, serum    Lymphoma 20S Proteasome (z) ELISA, serum   Thyroid carcinoma PA28-g (z) Western blot, immunocytochemistry, tumor biopsy  Breast, gastric, lung, brain, ovary, prostate, bladder, esophageal cancer p27 (#) Western blot, immunocytochemistry, tumor biopsy [86 – 91] Autoimmune diseases "
[Show abstract] [Hide abstract]
- "In the hippocampus, the NCI and NII were counted from sector CA1 to CA2, the short dimension of the contiguous sample field being aligned with the alveus. NCI also occur in the dentate gyrus fascia in FTLD-TDP (Woulfe et el., 2001; Kovari et al., 2004; Mackenzie et al., 2006) and were counted with the sample field aligned with the upper edge of the granule cell layer. The number of NCI and NII were counted in each sample field. "
ABSTRACT: Mutations of the progranulin (GRN) gene are a major cause of familial frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy (FTLD-TDP). We studied the spatial patterns of TDP-43 immunoreactive neuronal cytoplasmic inclusions (NCI) and neuronal intranuclear inclusions (NII) in histological sections of the frontal and temporal lobe in eight cases of FTLD-TDP with GRN mutation using morphometric methods and spatial pattern analysis. In neocortical regions, the NCI were clustered and the clusters were regularly distributed parallel to the pia mater; 58% of regions analysed exhibiting this pattern. The NII were present in regularly distributed clusters in 35% of regions but also randomly distributed in many areas. In neocortical regions, the sizes of the regular clusters of NCI and NII were 400-800 μm, approximating to the size of the modular columns of the cortico-cortical projections, in 31% and 36% of regions respectively. The NCI and NII also exhibited regularly spaced clustering in sectors CA1/2 of the hippocampus and in the dentate gyrus. The clusters of NCI and NII were not spatially correlated. The data suggest degeneration of the cortico-cortical and cortico-hippocampal pathways in FTLD-TDP with GRN mutation, the NCI and NII affecting different clusters of neurons.Histology and histopathology 02/2011; 26(2):185-90. · 2.24 Impact Factor
[Show abstract] [Hide abstract]
- "Very little pathology was observed to extend into CA3/4 in the cases studied and these areas were not sampled. NCI have been commonly observed in the DG fascia in FTLD-TDP (Mackenzie et al. 2006b; Woulfe et al. 2001; Kovari et al. 2004) and the sample field was aligned with the upper edge of the granule cell layer. The NCI (Fig. 2) are rounded, spicular, or skein-like in shape (Yaguchi et al. 2004; Davidson et al. 2007), while the GI (Figs. 2, 3) morphologically resemble the 'coiled bodies' reported in various tauopathies such as corticobasal degeneration, progressive supranuclear palsy, and argyrophilic grain disease. "
ABSTRACT: Studies suggest that frontotemporal lobar degeneration with transactive response DNA-binding protein of 43 kDa (TDP-43) proteinopathy (FTLD-TDP) is heterogeneous with division into four or five subtypes. To determine the degree of heterogeneity and the validity of the subtypes, we studied neuropathological variation within the frontal and temporal lobes of 94 cases of FTLD-TDP using quantitative estimates of density and principal components analysis (PCA). A PCA based on the density of TDP-43 immunoreactive neuronal cytoplasmic inclusions, oligodendroglial inclusions, neuronal intranuclear inclusions, and dystrophic neurites, surviving neurons, enlarged neurons, and vacuolation suggested that cases were not segregated into distinct subtypes. Variation in the density of the vacuoles was the greatest source of variation between cases. A PCA based on TDP-43 pathology alone suggested that cases of FTLD-TDP with progranulin (GRN) mutation segregated to some degree. The pathological phenotype of all four subtypes overlapped but subtypes 1 and 4 were the most distinctive. Cases with coexisting motor neuron disease (MND) or hippocampal sclerosis (HS) also appeared to segregate to some extent. We suggest: (1) pathological variation in FTLD-TDP is best described as a 'continuum' without clearly distinct subtypes, (2) vacuolation was the single greatest source of variation and reflects the 'stage' of the disease, and (3) within the FTLD-TDP 'continuum' cases with GRN mutation and with coexisting MND or HS may have a more distinctive pathology.Journal of Neural Transmission 12/2009; 117(2):227-39. DOI:10.1007/s00702-009-0350-6 · 2.87 Impact Factor